26
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Cisobitan® in Treatment of Prostatic Cancer

A Prospective Controlled Multicentre Study

, , , , , , , , , , , & show all
Pages 37-43 | Received 01 Apr 1981, Published online: 15 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

John S Mills & Graham A Showell. (2004) Exploitation of silicon medicinal chemistry in drug discovery. Expert Opinion on Investigational Drugs 13:9, pages 1149-1157.
Read now

Articles from other publishers (9)

Hirozumi Toyama, Masaharu Nakamura, Yuichi Hashimoto & Shinya Fujii. (2015) Design and synthesis of novel ROR inverse agonists with a dibenzosilole scaffold as a hydrophobic core structure. Bioorganic & Medicinal Chemistry 23:13, pages 2982-2988.
Crossref
Yu Kurihara, Yoshinori Yamanoi & Hiroshi Nishihara. (2013) Pd-catalyzed synthesis of symmetrical and unsymmetrical siloxanes. Chemical Communications 49:96, pages 11275.
Crossref
T. Řezanka & K. Sigler. 2008. Bioactive Natural Products (Part O). Bioactive Natural Products (Part O) 835 921 .
Stephen Gately & Robert West. (2007) Novel therapeutics with enhanced biological activity generated by the strategic introduction of silicon isosteres into known drug scaffolds. Drug Development Research 68:4, pages 156-163.
Crossref
Mike Shelley, Craig Harrison, Bernadette Coles, John Stafforth, Timothy Wilt & Malcolm Mason. (2006) Chemotherapy for hormone-refractory prostate cancer. Cochrane Database of Systematic Reviews.
Crossref
Graham A Showell & John S Mills. (2003) Chemistry challenges in lead optimization: silicon isosteres in drug discovery. Drug Discovery Today 8:12, pages 551-556.
Crossref
D. Raghavan & I. F. Tannock. 1989. Combination Therapy in Urological Malignancy. Combination Therapy in Urological Malignancy 225 253 .
K. Wierzba, B. Wańkowicz, E. Kamińska & A. Danysz. 1985. 367 406 .
Geoffrey D. Chisholm. (2006) Treatment of advanced cancer of the prostate. Seminars in Surgical Oncology 1:1, pages 38-55.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.